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Featured Application: Lung sonography and sonographic guided pulmonary interventions using
partial lung liquid filling.
Abstract: (200w) Lung ultrasound (LUS) is widely used for the diagnosis of pulmonary diseases such
as solid nodules and consolidations in contact with the pleural cavity. However, sonography for
processes of central disease remains impaired due to total sound reflection at the air tissue interfaces
in the ventilated lung. These acoustic barriers can be overcome by replacing intra-alveolar air with
liquid. Such filling has been reported using perfluorocarbon, saline or emulsions out of those. In order
to achieve acoustic access enabling the use of LUS, complete gas free content is required. Such
lung tissue - liquid compound will have untypical physical properties that might impact upon the
sonographic visualization of central structures. Up to now, the filling of the lung has been reported
for very specific applications and not classified regarding their sonographic findings. This work
was therefore motivated to review the literature for methods of lung liquid instillation, classifying
their methodological strength and limitations for achieving acoustic access and sonographic findings.
Finally, their use for ultrasound based clinical applications will be discussed and the need for research
will be outlined.
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1. Motivation
Ventilated lung parenchyma is well known as a total acoustic absorber [1] that impairs
intra-pulmonary sonography of consolidations, lung tumors, and central lymph nodes, vessels,
and bronchi. Despite these limitations, lung ultrasound (LUS) is widely used in clinical praxis for
the exclusion of pneumothoraxes [2], monitoring of extravascular water content [3], or diagnosis of
malignancies in contact with pleural cavity [4]. Sonography has shown a high precision comparable to
CT for detection and characterization of lung nodules in contact with chest wall [5]. These applications
reflect acoustic changes of the pleural cavity and their direct adjacent lung parenchyma. Approaches use
shear wave elastography showed feasibility of nodule detection in pleural proximity [6]. However, their
sonographic morphology and location to sensitive structures such as vascularity remains unknown.
Unlike with other organs, the gas content of lung parenchyma can be manipulated and therefore
acoustic access is generated. Atelectatic lung can achieve sonographic access, but the resulting random
collapse is associated with loss of anatomic orientation.
In contrast, instillation of liquids keeping the lung expanded overcomes this problem. Such liquid
administration using PerFluoroCarbon (PFC) [7] or saline [8] are used for diagnostic or therapeutic
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purposes in pneumology for decades. The fundamentals of lung filling for the use of LUS regarding their
sonographic findings have never been summarized and classified. These liquids have different physical
and physiological properties, which impacts upon ultrasound imaging and clinical applicability.
Therefore, this work was motivated to review the literature regarding lung filling methods and the
sonographic findings. Furthermore, the future impact on clinical applications and need for further
research will be discussed.
2. Perfluorocarbon (PFC) Filling
2.1. Methodology
The instillation of lung using PFC based liquids was introduced early in pneumology and neonatal
care. Herein, their specific physical-chemical properties are used as an inert volatile liquid, denser than
water with low surface tension as well as high oxygen/carbon dioxide solubility. Instilled hydrophobic
and biocompatible PFC is not resorbed by perfusion or tissue and remains in the alveolar airspace.
Under continued ventilation, PFCs transports oxygen and carbon dioxide, and therefore supports
maintaining the gas exchange.
Pulmonary PFC administration is clinically established for the management of acute lung distress
syndrome (ARDS) of preterm infants [9] as an effective technique improving the gas exchange with
less barotrauma in comparison to gas ventilation.
Recent work showed optimization and standardization strategies to control exogenously the
pulmonary gas exchange and temperature [10]. The so called liquid lung ventilation (LLV) is performed
partially on an isolated lung wing (PLV) or can be applied to both lungs, which is called total lung
ventilation (TLV). Such lung ventilation manages the entire oxygenation and gas exchange, requiring
exogenously PFC processing and ventilation control (Figure 1). Despite its use for treatment of
ARDS, the PFC filled lung can serve as a heat exchanger. This can lead to applications in oncology
as intrapulmonary hyperthermia [11] or as hypothermia for the management of acute traumatic
conditions [12].
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Figure 1. Schematic structure of a perfluorocarbon (PFC) liquid lung ventilator, requiring gas exchange
of O2 and CO2 using condenser, ventilation of liquids to lung by separated pups for inspiration and
expiration, and temperature control. Adapted with permission from Kohlhauer et al. [10].
The use of diagnostic imaging in PFC filled lung was hypothesized for Magnet Resonance MRI [13]
or Computer Tomography (CT) [14] imaging. The applicability of pulmonary PFC administration for
ultrasound imaging could be assumed due to the gas solubility, absorbing alveolar air and the safety of
PFC administration even as an intravenous contrast agent [15].
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2.2. Sonographic Imaging
The use of PFC lung filling has been intensively investigated and applied in pneumology
for decades, but only a few authors considered its further use for sonographic imaging. Initially,
Sekins et al. [16] hypothesized the use of sonography for the guidance of interventions in a patent.
Later work investigated the acoustic properties of PFC liquids (see Table 1) for such sonographic
use in large animal sheep models [17]. Herein, a strong hyperechoic character of PFC filled lung,
incapable of visualizing lung structure was reported. Only trans-pulmonary imaging of the beating
heart, in proximity to the chest wall, was described.
Later work investigated PFC filling in vivo by Lesser et al. [18] using porcine models and
Degnan et al. [19] in infants. In these undertakings, visualization of central structures was not found
and sonography appear as white lung syndrome with low penetrability in absence of A Lines (Figure 2).
Table 2 summarizes the literature with corresponding sonographic finding of a PFC filled lung.
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Table 1. Summary of published values for speed of sound, impedance as well as attenuation (A fn) for
several PFC liquids, saline @35 ◦C as well as alveolar tissue. The reflection coefficient of intensities is
based on the i pedance mismatch to alveolar lung tissue.
Liquid Used Speed of
Sound [m/s]
Impedance
[MRayl]
Reflection
Coefficient
Attenuation
A [dB/cmMHz] N
PFC - Perflubron [17] 580 1.08 4.7% (0.42 dB) 0.22 1.8
PFC- FC 77 [21] 560 0.96 7.9% (0.75 dB) 0.35 1.6
PFC-Decalin [17] 620 1.25 1.0% (0.087 dB) 0.20 1.3
Perfluorohexane [21] 482 0.79 13.5% (1.26 B) 0.35 1.6
Saline (35 ◦C) [23] 1520 1.53 0.03% (0.026 dB) 0.0014 2.0
Alveol r tissue [22] 1640 1.72 0% 0.21 1.1
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Table 2. Summary of literature related to sonographic imaging of lung during liquid instillation.
Paper Year Method/Model/Liquid Findings
Sekins et al. 2004 TLV—sheepPFC—Perflubron
- trans pulmonary cardiac visualization
- maximum penetration depth 2–4 cm
- bright echogenicity of
lung/white lung
- no bronchial and vascularity detected
Degnan et al. 2018 PLV—InfantsPF—Perflubron
- bright echogenicity of
lung/white lung
- no bronchial and vascularity detected
Lesser et al. 1998 OLF—porcine modelPFC—PF77
- bright echogenicity of
lung/white lung
- no bronchial and vascularity detected
Lesser et al. 1999 OLF—porcine modelSaline 0.9%
- unimpaired lung ultrasound
- visualization of simulated nodules
Lesser at al. 2013
OLF—porcine model
and ex vivo human lung
saline 0.9%
- complete lung imaging
- hypoechoic lung tumors
- demarcation of adjacent organs
- hypoechoic bronchial and vasculature
DePew et al. 2014 OLF—human cadaversaline 0.9%
- limited lung imaging
- residual gas
- sub-centimeter imaging of a forceps
Lesser et al. 2018
OLF—porcine model
and ex vivo human lung
saline 0.9%
- unimpaired lung imaging
- visualization of simulated nodules
- hypoechoic lung tumors
- bright echogenicity of
puncture needle
2.3. Clinical Relevance
Due to the impaired sonography, specific clinical indications for the use of LUS during PFC liquid
ventilation have not been investigated. Despite these limitations, the use of diffuse hyperthermia
insonated from cylindrical or piston transducer of low frequency (500 kHz–1 MHz) have been
investigated in PFC liquid lung without sonographic guidance [17].
2.4. Discussion
Lung filling with PFC is safe, with a low complication rate, and represents an accepted modality
that experienced pneumological centers are used to handling. Limiting long recovery time due to
their biological inertness requires complete vaporization of intrapulmonary liquid [20]. Sonography of
PFC filled lung has been inadequately studied thus far. The underlying assumption of complete gas
exchange has not been proven.
It is important to notice that PFC has a much lower speed of sound than solid tissue (Table 1).
Images based on time of flight (TOF) assumption would be falsified and require adoption for image
reconstruction. Such a correction algorithm would need to distinguish normal tissue with typical
water-like speed of sound and PFC filled lung to derive realistic images representing anatomic
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dimensions. In addition, the reported visualization depth of 2–4 cm in PFC filled sheep lung [17] was
estimated using such general sonography. Therefore, a realistic penetration depth of only 1–3 cm can
be assumed.
All authors reported a bright echogenic character of PFC lung, similar to white lung syndrome.
The sonographic impairment cannot be explained by PFC attenuation, which is in range of
0.3–0.4 dB/cm/MHz [17,21], slightly lower than solid tissue (0.5–0.8 dB/cm/MHz). When imaging
liquid PFC the medium appears hypoechoic similar to water with clear visualization of backstop
structures [19]. This indicates multiple reflections of ultrasound waves due to the impedance mismatch
in flooded lung as a PFC-tissue compound. Given an impedance of 1.7 MRayl and an attenuation of
0.2 dB/cm MHz of atelectatic lung [22], the reflection coefficients for ultrasound intensities at a PFC
interface varies between 1%–13% (Table 1). Theoretically, multiple reflections of ultrasound waves
would lead to a 10–130 dB intensity loss within 1 cm of lung penetration (∅100 µm alveoli) and therefore
impair sonographic imaging. In addition, the speed of sound difference between lung parenchyma and
PFC would lead to refraction and focal distortion for using any focused ultrasound application (HIFU).
These facts highlight the unsuitability of PFC filled lung out for sonographic imaging. Despite the
acoustic high intensity loss, an image reconstruction algorithm would be required for realistic imaging
correcting of TOF differences between liquid and tissue. PFC-Decalin might provide the best properties
for sonographic visualization but haven’t as yet been used for ultrasound imaging in the lung so far.
3. Saline-Based One Lung Filling (OLF)
3.1. Methodology
Instillation of the lung with physiological saline is used for the removal of pathologic catabolite
products [24]. However, such lung lavage does not necessarily generate acoustic access in a quality
required for sonographic imaging. In contrast to PFC, saline does not absorb gas and therefore filling
can only be performed in one lung requiring the ventilation of the contralateral side (Figure 3). Such
OLF (One Lung Filling) requires lung separation and one lung ventilation (OLV) using double lumen
tubes (DLT) as commonly performed in thoracic surgery.
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Figure 3. One lung floo ing ( F) scheme where one lung wing is filled with saline, while the
ventila ed contral teral ung i cted to a ventilation system with transcutan ous/endobronchial
sonographic maging. (Ada t it permi sion from Less r et al. [25]).
Acoustic impedance of saline is almost identical to tissue with low attenuation, avoiding impedance
mismatch and scattering of ultrasound waves when passing the flooded lung parenchyma (Table 1).
Initially, Lesser et al. [25] used physiological saline for these reasons resulting in an unimpaired
sonographic v sualization of c ntral pulmonary structures in a porcine model. The work was intended
for sonographic guiding during th racoscopic or vide -thoracoscopic surgery (VATS) wher telectasis
was induced by a chest incision followed by the filling of the lung [26]. Motivated by these results,
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non-invasive strategies proofing OLF without chest incision was investigated. A slower lung filling
time of 20 min was documented, but imaging results were unimpaired similar to filling after atelectasis.
OLF is reversible and the liquid is drained out partially followed by immediate re-ventilation
using the same settings for booth lungs. The remaining saline is being absorbed completely by
perfusion within approximately 30 min [27]. The safety of OLF was well investigated and seen as not
causing deficiencies of oxygenation and pulmonary haemodynamic [28]. In addition, inflammatory
response [29] and surfactant loss [30] were in the physiological range.
3.2. Imaging Findings
During stable flooding in-vivo with saline, unimpaired imaging without remaining air was
achieved. The lung parenchyma appears homogeneous with enhanced echogenicity, where vessels
and bronchi are well demarked as hypoechoic structures [18]. Trans-pulmonary imaging visualized
adjacent organs such as the liver or heart (Figure 4). Doppler imaging in flooded lung is feasible and
useful to detect vessels (Figure 5). No limitations regarding penetration depth were documented.
High frequency linear probes (10–15 MHz) were recommended for high resolution imaging such as for
small bronchi or vessels [22] (Figure 6). Using ex-vivo models and simulated intra-pulmonary nodules
in-vivo, a reliable nodule detection of primary lung cancer as well as metastases were found. The tumor
mass appears hypoechoic, surrounded by hyperechoic flooded lung, resulting in a high detection
rate of about 100% of malignant pulmonary nodules (Figure 7), as well as simulated nodules [31].
Interestingly, the visualization is aggravated only for the bronchoalveolar cell carcinoma. The specific
growth along the alveolar surface caused an echo-enhanced appearance with similar characteristics to
flooded lung parenchyma [18].
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far, OLF in-vi o was been performed only using large animal mode s. The promising imag
results hav no brought OLF into clinical practice. Therefore, consecutive work investigated minimal
a ive procedures, which justified OLF. Herein, sonographic guided tissue sampling was successfully
evaluated, resulting in a high (98%) puncture rate [32]. Complications such as pneumothoraxes,
which occurs frequently during lung puncture in a ventilated condition, was not found during OLF.
The liquid’s gravity causes expansion of the lung and avoids pneumothoraxes. These results indicate
the favorability of applicator-based procedures during OLF in comparison to ventilated lung. Therefore,
the future use of such interstitial based ablation (e.g., MW, RFA, LITT, Electrophoresis) using ultrasound
guidance should be conducted in future research.
Ideally, thermal ablation should be performed non-invasively. Substantial work investigating the
acoustic conditions in saline flooded lung revealed ideal conditions for non-invasive ablation using
therapeutic ultrasound (HIFU). Saline flooded lung provides a low attenuation, minimizing intensity
loss and increasing HIFU temperature induction in targeted central cancer tissue. It was found that
therapeutic ultrasound intensities interact with malignant tissue inducing lethal thermal damage.
The same acoustic dose targeted to the healthy parenchyma causes a non-lethal temperature rise,
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therefore leaving the healthy lung parenchyma unaffected [22]. Even acoustic cavitation not causes
erosive damage to lung parenchyma at intensities below than 10.000 W/cm2 [33].
In addition to HIFU ablation of pulmonary malignancies, Xie et al. [34] proposed the use for
OLF and HIFU for the treatment of tuberculosis. Using the lung as a trans-pulmonary path, targets
in adjacent organs such as in the upper liver dome could be targeted by therapeutic ultrasound [35].
Recent work investigated optimal HIFU settings and providing treatment planning modalities [36].
Challenging, are optimal design settings, avoiding beam defocusing and rib heating, which requires
modern HIFU modalities such as non-thermal histotripsy [37] or endobronchial insonation [38].
3.4. Discussion
It was found that saline-based OLF results in unimpaired visualization of lung in the absence
of remaining gas content using B-Mode sonography. The limited visualization during OLF using
cadavers indicates the importance of perfusion for gas resorption [39]. Saline as an acoustic matched
liquid to parenchyma is an ideal medium where effects of refraction and scattering as well as
attenuation of ultrasound waves are minimized in lung as a liquid-tissue compound. OLF has been
investigated consecutively, starting with physiological and safety aspects via acoustic modelling to
clinical applications. It required two decades to pave the way path from the idea towards evaluation of
its clinical use for diagnostic and therapeutic ultrasound applications.
The high sonographic nodule detection rate and clear demarcation from vascular and bronchial
structure is valuable, not requiring contrast agents or fusion techniques. During OLF, anatomic
orientation is given due to visualization of adjacent organs. For complementation of the sonographic
findings, modern imaging modalities such as elastography or contrast agents should be investigated in
future work, improving visualization of bronchoalveolar cell carcinoma.
It is likely that OLF will not be applicable for a diagnosis requiring full sedation and insertion
of a DLT. Its use for sonographic guidance of therapeutic interventions might justify the invasivity.
Favorable for interventions during OLF, are the high nodules detection rate, with the demarcation
of vascularity and reduction of ventilation associated motion [40]. The reduction of intrapulmonary
perfusion in the flooded lung [28] reduces the risk of hemorrhage during puncture and eliminates
possible perfusion associated heat flux when performing thermal ablation. In combination with
real-time sonography providing high resolution, low costs, and absence of radiation, LUS guiding
during OLF is more favorable than CT or MRI.
Most promising for the clinical use of OLF is the combination of diagnostic lung ultrasound for
guidance of therapeutic ultrasound ablation (HIFU) [41]. From such a non-invasive ablation of central
lung malignancies the field of pulmonary oncology might benefit from. However, the translation to
human subjects is hindered due to the unavailability of clinical HIFU systems capable of trans-costal
focusing. Several authors have proposed methods to focus HIFU behind the rib cage [42], but these
methods have not been implemented in clinical systems to date.
A limitation of OLF, arises from the procedure duration. This operating window was investigated
so far only up to 60–90 min, which is sufficient for sonographic guided tissue sampling, MWA
or catheter-based ablation (typical 10–15min). During HIFU ablation the procedure time might
exceed these limits depending on ablation speed and tumor size. Future work should investigate
methodological optimization to expand OLF duration without the impairment of acoustic access.
4. Summary and Outlook
Lung ultrasound has been used for decades, becoming a valid clinical tool for characterizing
peripheral-pleural lung consolidations. In contrast to CXR, which determines density variations, LUS
can differentiate atelectasis, pneumonia, lung infarct, and is useful for the diagnosis of heart failure
and pneumothorax.
In order to achieve unimpaired ultrasound imaging of the entire lung, a replacement of gas by a
liquid fraction is needed. So far, two methods have been investigated for the purpose of endobronchial
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liquid instillation. Herein, OLF using saline generates unimpaired sonographic imaging. The use
of inert PFC has physiological advances although it is acoustically inappropriate. The liquid must
have identical properties, with regard to speed of sound and impedance, as the alveolar tissue. Such
properties so far can only be provided by physiological saline (see Table 1). Using PFC liquids
with deviating acoustic properties, sound diffraction and scattering appear in the flooded alveolar
parenchyma, which impairs any sonographic imaging. Therefore, no progress has been seen in the
improvement of PFC based ultrasound applications in lung over processes performed with saline based
OLF. There are no further needs in optimizing the acoustic conditions under saline OLF. Sonographic
tumor detection rate, as well as visualization of intra-parenchymal vascular and bronchial structures
are superior, and imaging in depth is slightly better than in abdominal organs.
Given the valuable B Mode visualization during saline OLF, most of the accepted diagnostic
and sonographic guided interventions are applicable in the lung as practiced for abdominal organs
such as the liver. Particular for minimal invasive interventions, OLF is justifiable and beneficial.
Performing OLF was initially motivated out of pulmonary oncology for the management of central
lung nodules using sonographic guidance during VATS. Later work showed the feasibility of complete
new minimal-invasive treatment strategies, such as non-invasive HIFU ablation of central lung nodules.
However, despite the promising results, OLF related research was based on pre-clinical models.
Therefore, studies showing the advances of OLF based sonographic guided interventions in a clinical
setting are of high demand. The investigation of puncture hit- and complication rate of sonographic
guided biopsy during OLF in comparison with CT would be the logical next step. Herein, all the
techniques are clinically established, and the outcome is immediately measurable.
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Abbreviations
CO2 Carbone Dioxide
CXR Chest X Ray
CT Computer Tomography
DLT Double Lumen tube
FUS Focused Ultrasound Surgery
HIFU High Intensity Focused Ultrasound
LUS Lung Ultrasound
MRI Magnet Resonance Imaging
OLF One Lung Flooding
O2 Oxygen
PLV Partial Lung Liquid Ventilation
PFC PerFluoroCarbon liquids
TLV Total Lung Liquid Ventilation
VATS Video Assisted Thoracoscopic Surgery
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